We are live on ! Find out more
CGL

Clarius Group LLC Portfolio holdings

AUM $1.75B
1-Year Est. Return 19.04%
This Fund
S&P 500
This Quarter Est. Return
+3.84%
1 Year Est. Return
+19.04%
3 Year Est. Return
+92.07%
5 Year Est. Return
+98.79%
10 Year Est. Return
+415.93%
AUM
$1.75B
AUM Growth
+$62.2M
Cap. Flow
+$9.49M
Cap. Flow %
0.54%
Top 10 Hldgs %
59.64%
Holding
411
New
13
Increased
98
Reduced
159
Closed
27

Sector Composition

Rank Sector Weight
1 Industrials 16.65%
2 Technology 15.34%
3 Consumer Discretionary 6.93%
4 Financials 3.82%
5 Healthcare 3.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSX icon
151
Boston Scientific
BSX
$63.9B
$762K 0.04%
7,987
-2
-0% -$196
QQQJ icon
152
Invesco NASDAQ Next Gen 100 ETF
QQQJ
$1.12B
$759K 0.04%
20,601
PM icon
153
Philip Morris
PM
$303B
$741K 0.04%
4,618
-1,450
-24% -$225K
ADP icon
154
Automatic Data Processing
ADP
$97.2B
$738K 0.04%
2,868
-128
-4% -$34.1K
BBVA icon
155
Banco Bilbao Vizcaya Argentaria
BBVA
$145B
$733K 0.04%
31,426
SHEL icon
156
Shell
SHEL
$243B
$733K 0.04%
9,969
BKNG icon
157
Booking.com
BKNG
$138B
$718K 0.04%
3,350
ESGV icon
158
Vanguard ESG US Stock ETF
ESGV
$13.2B
$711K 0.04%
5,877
+446
+8% +$53.5K
UBS icon
159
UBS Group
UBS
$173B
$704K 0.04%
15,199
+303
+2% +$12.2K
PFE icon
160
Pfizer
PFE
$141B
$701K 0.04%
28,141
-759
-3% -$19.1K
T icon
161
AT&T
T
$160B
$700K 0.04%
28,181
-6,536
-19% -$165K
XLY icon
162
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.3B
$678K 0.04%
5,682
-694
-11% -$82.3K
SANA icon
163
Sana Biotechnology
SANA
$868M
$676K 0.04%
166,065
-46,435
-22% -$208K
MO icon
164
Altria Group
MO
$121B
$671K 0.04%
11,631
-1,235
-10% -$74.6K
ALL icon
165
Allstate
ALL
$64.8B
$665K 0.04%
3,197
+39
+1% +$7.98K
REGN icon
166
Regeneron Pharmaceuticals
REGN
$68.3B
$657K 0.04%
851
+6
+0.7% +$4.08K
INTU icon
167
Intuit
INTU
$77.8B
$654K 0.04%
988
-411
-29% -$272K
NOC icon
168
Northrop Grumman
NOC
$74.6B
$651K 0.04%
1,142
-284
-20% -$165K
TMUS icon
169
T-Mobile US
TMUS
$207B
$646K 0.04%
3,182
-40
-1% -$8.48K
SCHX icon
170
Schwab US Large- Cap ETF
SCHX
$71.7B
$638K 0.04%
23,712
EXPD icon
171
Expeditors International
EXPD
$23.2B
$630K 0.04%
4,226
+11
+0.3% +$1.5K
COR icon
172
Cencora
COR
$58.5B
$627K 0.04%
1,855
+2
+0.1% +$682
BMY icon
173
Bristol-Myers Squibb
BMY
$124B
$621K 0.04%
11,510
-1,027
-8% -$49.4K
LYEL icon
174
Lyell Immunopharma
LYEL
$315M
$614K 0.04%
19,958
CEG icon
175
Constellation Energy
CEG
$98.2B
$607K 0.03%
1,719
-93
-5% -$33.8K

Similar funds

Clarius Group LLC's Q4 2025 Portfolio in Review

As of Q4 2025, Clarius Group LLC held 411 positions worth $1.75B, up 3.7% from $1.69B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Clarius Group LLC's Q4 2025 filing shows 13 new, 98 increased, 159 reduced and 27 closed positions. Its largest new stake was Capital Group Global Equity ETF: 1,103,189 shares worth $34.9M. The largest sale was Microsoft, an estimated $4.12M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Clarius Group LLC's largest Q4 2025 buy was Capital Group Global Equity ETF: 1,103,189 shares worth $34.9M.
  • Clarius Group LLC added most to Vanguard Ultra-Short Bond ETF in Q4 2025, an estimated $5.25M increase.
  • Clarius Group LLC's biggest Q4 2025 reduction was Microsoft, cutting an estimated $4.12M.
  • Clarius Group LLC fully exited KKR & Co in Q4 2025, selling an estimated $650K.
  • Clarius Group LLC's ten largest holdings make up 60% of its $1.75B portfolio in Q4 2025.
  • Clarius Group LLC opened 13 new positions and closed 27 in Q4 2025.
  • Clarius Group LLC's portfolio value rose 3.7% quarter-over-quarter to $1.75B.

Based on Clarius Group LLC's 13F filing for Q4 2025, filed 14 Jan 2026.